{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:14:47Z","timestamp":1783646087976,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":59,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"This research was partially supported by the University Grant Commission .","award":["(Grant no: FRG-80\/81-HS-07)"],"award-info":[{"award-number":["(Grant no: FRG-80\/81-HS-07)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic Obstructive Pulmonary Disease (COPD) is a major health concern in low and middle-income countries. Drug-related problems (DRPs), defined as issues in drug therapy that interfere with desired outcomes, add further challenges. Evidence on the prevalence and costs burden of DRPs in COPD patients is limited. This study assessed the prevalence of DRPs, identified associated factors, and compared prescription costs between patients with and without DRPs. A cross-sectional study was conducted among 156 COPD patients attending a first referral hospital in Dailekh, Nepal, from May to September 2024. Data were collected through in-person interviews using a structured questionnaire and medical record review. DRPs were classified using the Pharmaceutical Care Network 9.1 system. Prevalence and medications costs were reported. Factors associated with DRPs were analyzed using bivariate tests and multivariate logistic regression. Medication costs were calculated using hospital pharmacy prices and mean costs with 95% confidence interval were compared across groups. The prevalence of DRPs was 71.8%, with patients experiencing an average of 1.45 DRPs. Male patients (AOR 3.0; 95% CI 1.2\u20137.4), those from disadvantaged ethnic group (AOR 3.3; 95% CI 1.1\u20139.8), and patients with comorbidity (AOR 2.7; 95% CI 1.2\u20135.9) were more likely to have DRPs. The mean cost per patient was NRs. 6543\u2009\u00b1\u20091423.4). DRPs are highly prevalent among COPD patients and contribute to significant financial burden. Strengthening the role of pharmacists and other health professionals in identifying and preventing DRPs is essential. Targeted interventions for high-risk groups can help reduce DRPs, improve treatment outcomes, and lessen the economic impact on patients.<\/jats:p>","DOI":"10.1038\/s41598-026-51951-8","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T06:15:12Z","timestamp":1778566512000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of drug-related problems and associated factors among patients with chronic obstructive pulmonary disease in Dailekh, Nepal: a cross-sectional study"],"prefix":"10.1038","volume":"16","author":[{"given":"Lok Raj","family":"Pant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Adhikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishnu","family":"Khanal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nim Bahadur","family":"Dangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"issue":"12","key":"51951_CR1","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.3390\/pathogens11121513","volume":"11","author":"Y Rosenwasser","year":"2022","unstructured":"Rosenwasser, Y., Berger, I. & Loewy, Z. G. Therapeutic approaches for chronic obstructive pulmonary disease (COPD) exacerbations. Pathogens 11 (12), 1513 (2022).","journal-title":"Pathogens"},{"issue":"7","key":"51951_CR2","first-page":"34","volume":"1","author":"JF Devine","year":"2008","unstructured":"Devine, J. F. Chronic obstructive pulmonary disease: An overview. Am. Health Drug Benefits. 1 (7), 34 (2008).","journal-title":"Am. Health Drug Benefits"},{"issue":"1","key":"51951_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/resp.14349","volume":"28","author":"HY Li","year":"2023","unstructured":"Li, H. Y. et al. Global, regional and national burden of chronic obstructive pulmonary disease over a 30\u2010year period: estimates from the 1990 to 2019 global burden of disease study. Respirology 28 (1), 29\u201336 (2023).","journal-title":"Respirology"},{"key":"51951_CR4","doi-asserted-by":"crossref","unstructured":"Adhikari, T. B. et al. Prevalence of chronic obstructive pulmonary disease and its associated factors in Nepal: Findings from a community-based household survey. Int. J. Chronic Obstr. Pulm. Dis. 29, 2319\u20132331 (2020).","DOI":"10.2147\/COPD.S268110"},{"key":"51951_CR5","unstructured":"Budhathoki, P. et al. Prevalence and risk factors of COPD in Nepal: A systematic review and meta-analysis."},{"issue":"2","key":"51951_CR6","first-page":"58","volume":"4","author":"A Agust\u00ed","year":"2022","unstructured":"Agust\u00ed, A. et al. Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary. J. Pan Afr. Thorac. Soc. 4 (2), 58\u201380 (2022).","journal-title":"J. Pan Afr. Thorac. Soc."},{"key":"51951_CR7","doi-asserted-by":"crossref","unstructured":"Karki, K. B. et al. Factors associated with chronic obstructive pulmonary diseases in Nepal: Evidence from a nationally representative population-based study. Int. J. Chronic Obstr. Pulm. Dis. 20, 1109\u20131118 (2021).","DOI":"10.2147\/COPD.S295321"},{"key":"51951_CR8","unstructured":"NHRC M. MEOR Burden of disease 2017: a country report based on the global burden of disease 2017 study. Kathmandu, Nepal. Nepal health research Council (NHRC), Ministry of health and population (MoHP) and monitoring evaluation and operational research(MEOR. Nepal, 2019.[Google Scholar]. (2019)."},{"issue":"2","key":"51951_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3126\/jnhls.v3i2.72673","volume":"3","author":"CP Acharya","year":"2024","unstructured":"Acharya, C. P., Yadav, A., Paudel, K., Thapaliya, R. & Duwadi, V. Medication adherence and health related quality of life among patients with chronic obstructive pulmonary disease in Pokhara. J. Natl. Heart Lung Soc. Nepal. 3 (2), 123\u2013130 (2024).","journal-title":"J. Natl. Heart Lung Soc. Nepal."},{"issue":"1","key":"51951_CR10","doi-asserted-by":"publisher","first-page":"e0296091","DOI":"10.1371\/journal.pone.0296091","volume":"19","author":"K Sharma","year":"2024","unstructured":"Sharma, K., Subba, H. K., Poudyal, S. & Adhikari, S. Effect of self-management intervention on patients with chronic obstructive pulmonary diseases, Chitwan, Nepal. PLoS One. 19 (1), e0296091 (2024).","journal-title":"PLoS One"},{"issue":"1","key":"51951_CR11","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s12889-020-8404-7","volume":"20","author":"UN Yadav","year":"2020","unstructured":"Yadav, U. N. et al. Self-management practice, associated factors and its relationship with health literacy and patient activation among multi-morbid COPD patients from rural Nepal. BMC Public. Health. 20 (1), 300 (2020).","journal-title":"BMC Public. Health"},{"key":"51951_CR12","unstructured":"Pharmaceutical Care Network Europe Association. Pharmaceutical Care Network Europe [Internet]. 2020 [cited 2025 Jan 15]. https:\/\/www.pcne.org\/"},{"issue":"1","key":"51951_CR13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s11096-015-0213-1","volume":"38","author":"R Lenssen","year":"2016","unstructured":"Lenssen, R. et al. Analysis of drug-related problems in three departments of a German University hospital. Int. J. Clin. Pharm. 38 (1), 119\u2013126 (2016).","journal-title":"Int. J. Clin. Pharm."},{"key":"51951_CR14","unstructured":"World Health Organization. Medication Without Harm [Internet]. 2017 [cited 2025 Aug 7]. https:\/\/www.who.int\/initiatives\/medication-without-harm"},{"issue":"2","key":"51951_CR15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1023\/A:1015570104121","volume":"24","author":"HJ Beijer","year":"2002","unstructured":"Beijer, H. J. & De Blaey, C. J. Hospitalisations caused by adverse drug reactions (ADR): A meta-analysis of observational studies. Pharm. World Sci. 24 (2), 46\u201354 (2002).","journal-title":"Pharm. World Sci."},{"key":"51951_CR16","unstructured":"World Health Organization. WHO launches global effort to halve medication-related errors in 5 years. 2017 [cited 2025 Sep 11]. WHO Launches Global Effort to Halve Medication-Related Errors in 5 Years. https:\/\/www.who.int\/news\/item\/29-03-2017-who-launches-global-effort-to-halve-medication-related-errors-in-5-years"},{"issue":"1","key":"51951_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13561-024-00481-y","volume":"14","author":"M Durand","year":"2024","unstructured":"Durand, M., Castelli, C., Roux-Marson, C., Kinowski, J. M. & Leguelinel-Blache, G. Evaluating the costs of adverse drug events in hospitalized patients: A systematic review. Health Econ. Rev. 14 (1), 11 (2024).","journal-title":"Health Econ. Rev."},{"issue":"1_suppl","key":"51951_CR18","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.4103\/0976-500X.120957","volume":"4","author":"J Sultana","year":"2013","unstructured":"Sultana, J., Cutroneo, P. & Trifir\u00f2, G. Clinical and economic burden of adverse drug reactions. J. Pharmacol. Pharmacother. 4 (1_suppl), S73\u2013S77 (2013).","journal-title":"J. Pharmacol. Pharmacother."},{"issue":"6","key":"51951_CR19","doi-asserted-by":"publisher","first-page":"e073777","DOI":"10.1136\/bmjopen-2023-073777","volume":"13","author":"AK Sendekie","year":"2023","unstructured":"Sendekie, A. K., Kasahun, A. E., Limenh, L. W., Dagnaw, A. D. & Belachew, E. A. Clinical and economic impact of adverse drug reactions in hospitalised patients: prospective matched nested case\u2013control study in Ethiopia. BMJ Open. 13 (6), e073777 (2023).","journal-title":"BMJ Open."},{"key":"51951_CR20","doi-asserted-by":"crossref","unstructured":"Al-Worafi, Y. M. Drug-related problems. In Drug Safety in Developing Countries, 105\u2013117 (Academic, 2020).","DOI":"10.1016\/B978-0-12-819837-7.00009-1"},{"issue":"6","key":"51951_CR21","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1007\/s11096-019-00913-4","volume":"41","author":"Q Li","year":"2019","unstructured":"Li, Q. et al. Drug-related problems among hospitalized patients with COPD in mainland China. Int. J. Clin. Pharm. 41 (6), 1507\u20131515 (2019).","journal-title":"Int. J. Clin. Pharm."},{"key":"51951_CR22","first-page":"100528","volume":"16","author":"RB Thapa","year":"2024","unstructured":"Thapa, R. B., Dahal, P., Karki, S. & Mainali, U. K. Exploration of drug therapy related problems in a general medicine ward of a tertiary care hospital of Eastern Nepal. Explor. Res. Clin. Social Pharm. 16, 100528 (2024).","journal-title":"Explor. Res. Clin. Social Pharm."},{"issue":"11","key":"51951_CR23","doi-asserted-by":"publisher","first-page":"e0309781","DOI":"10.1371\/journal.pone.0309781","volume":"19","author":"S Chapagain","year":"2024","unstructured":"Chapagain, S. et al. Drug-related problems among type 2 diabetic patients in Sunwal Municipality of Western Nepal. PLoS One. 19 (11), e0309781 (2024).","journal-title":"PLoS One"},{"key":"51951_CR24","doi-asserted-by":"crossref","unstructured":"Hasan, S., Al-Omar, M. J., AlZubaidy, H. & Al-Worafi, Y. M. Use of medications in Arab countries. In Handbook of Healthcare in the Arab World, 1\u201342 (Springer, 2019).","DOI":"10.1007\/978-3-319-74365-3_91-1"},{"key":"51951_CR25","unstructured":"Government of Nepal. PEN-Plus Clinical Protocol for Management of Severe & Chronic NCDs in the First Level Referral Hospitals of Nepal [Internet]. 2023 [cited 2025 Aug 10] p. 252. https:\/\/kioch.org.np\/almacenamiento\/2025\/06\/PEN-Plus-Clinical-Protocol-Updated_Oct.pdf"},{"key":"51951_CR26","unstructured":"Nepal Statistics Office NSO. National Population and and Housing Census 2021 [Internet]. 2021 [cited 2025 Aug 3]. https:\/\/censusnepal.cbs.gov.np\/results"},{"key":"51951_CR27","unstructured":"Health Service office 2081. District Annul Health Report 2080\/81 [Internet]. Asshoj p. 124. (2081). https:\/\/hsodailekh.gov.np\/wp-content\/uploads\/2025\/04\/Annual-Report-Dailekh-2080-81_Oct_26-2024-1.pdf"},{"key":"51951_CR28","doi-asserted-by":"crossref","unstructured":"Adhikari, T. B., Neupane, D. & Kallestrup, P. Burden of COPD in Nepal. Int. J. Chronic Obstr. Pulm. Dis. 9, 583\u2013589 (2018).","DOI":"10.2147\/COPD.S154319"},{"issue":"2","key":"51951_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.18549\/PharmPract.2023.2.2796","volume":"21","author":"U Acharya","year":"2023","unstructured":"Acharya, U. et al. Pattern of drug therapy related problems encountered by clinical pharmacists in a critical care setting in Nepal. Pharm. Pract. (Granada). 21 (2), 13 (2023).","journal-title":"Pharm. Pract. (Granada)"},{"key":"51951_CR30","unstructured":"Government of Nepal. Hospital pharmacy service guideline, 2015. MoHa Popul Ed Ramshahpath Kathmandu Gov Nepal. (2015)."},{"key":"51951_CR31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.rmed.2016.10.006","volume":"120","author":"S Apikoglu-Rabus","year":"2016","unstructured":"Apikoglu-Rabus, S., Yesilyaprak, G. & Izzettin, F. V. Drug-related problems and pharmacist interventions in a cohort of patients with asthma and chronic obstructive pulmonary disease. Respir. Med. 120, 109\u2013115 (2016).","journal-title":"Respir. Med."},{"key":"51951_CR32","doi-asserted-by":"publisher","first-page":"1049289","DOI":"10.3389\/fphar.2022.1049289","volume":"13","author":"MY Bektay","year":"2023","unstructured":"Bektay, M. Y., Sancar, M., Okyaltirik, F., Durdu, B. & Izzettin, F. V. Investigation of drug-related problems in patients hospitalized in chest disease wards: A randomized controlled trial. Front. Pharmacol. 13, 1049289 (2023).","journal-title":"Front. Pharmacol."},{"key":"51951_CR33","first-page":"16","volume":"8","author":"GB Meknonnen","year":"2017","unstructured":"Meknonnen, G. B., Biarra, M. K., Tekle, M. T. & Bhagavathula, A. S. Assessment of drug related problems and its associated factors among medical ward patients in university of gondar teaching hospital, northwest Ethiopia: a prospective cross-sectional study. J. Basic. Clin. Pharma. 8, 16\u201321 (2017).","journal-title":"J. Basic. Clin. Pharma"},{"issue":"5","key":"51951_CR34","doi-asserted-by":"publisher","first-page":"e0003128","DOI":"10.1371\/journal.pgph.0003128","volume":"4","author":"B Adhikari","year":"2024","unstructured":"Adhikari, B. et al. Procurement process and shortages of essential medicines in public health facilities: A qualitative study from Nepal. PLOS Glob. Public. Health. 4 (5), e0003128 (2024).","journal-title":"PLOS Glob. Public. Health"},{"key":"51951_CR35","unstructured":"GOLD Reports [Internet]. Global Initiative for Chronic Obstructive Lung Disease - GOLD. 2022 [cited 2025 Oct 2]. https:\/\/goldcopd.org\/2022-gold-reports\/"},{"issue":"4","key":"51951_CR36","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/jgs.15767","volume":"67","author":"DM Fick","year":"2019","unstructured":"Fick, D. M. et al. American Geriatrics Society Beers Criteria Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J. Am. Geriatr. Soc. 67 (4), 674\u2013694 (2019).","journal-title":"J. Am. Geriatr. Soc."},{"key":"51951_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cpr.2017.10.012","volume":"66","author":"RK McHugh","year":"2018","unstructured":"McHugh, R. K., Votaw, V. R., Sugarman, D. E. & Greenfield, S. F. Sex and gender differences in substance use disorders. Clin. Psychol. Rev. 66, 12\u201323 (2018).","journal-title":"Clin. Psychol. Rev."},{"issue":"4","key":"51951_CR38","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s40615-015-0101-3","volume":"2","author":"A Baehr","year":"2015","unstructured":"Baehr, A., Pe\u00f1a, J. C. & Hu, D. J. Racial and ethnic disparities in adverse drug events: a systematic review of the literature. J. Racial Ethnic Health Disparities. 2 (4), 527\u2013536 (2015).","journal-title":"J. Racial Ethnic Health Disparities"},{"issue":"7","key":"51951_CR39","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1093\/heapol\/czv137","volume":"31","author":"E Saito","year":"2016","unstructured":"Saito, E. et al. Inequality and inequity in healthcare utilization in urban Nepal: A cross-sectional observational study. Health Policy Plann. 31 (7), 817\u2013824 (2016).","journal-title":"Health Policy Plann."},{"key":"51951_CR40","doi-asserted-by":"crossref","unstructured":"Suen, K., Shrestha, S., Osman, S. & Paudyal, V. Association between patient race\/ethnicity, health literacy, socio-economic status, and incidence of medication errors: A systematic review. J. Racial Ethnic Health Disparities. 3, 1\u20132 (2025).","DOI":"10.1007\/s40615-025-02407-8"},{"issue":"2","key":"51951_CR41","doi-asserted-by":"publisher","first-page":"e0271650","DOI":"10.1371\/journal.pone.0271650","volume":"18","author":"R Asiri","year":"2023","unstructured":"Asiri, R., Todd, A., Robinson-Barella, A. & Husband, A. Ethnic disparities in medication adherence? A systematic review examining the association between ethnicity and antidiabetic medication adherence. PLoS One. 18 (2), e0271650 (2023).","journal-title":"PLoS One"},{"issue":"1","key":"51951_CR42","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12902-025-02011-1","volume":"25","author":"FB Tamene","year":"2025","unstructured":"Tamene, F. B. et al. Polypharmacy and associated factors among patients with type two diabetes mellitus with comorbidity: A multicenter cross-sectional study in Northwest Ethiopia. BMC Endocr. Disord. 25 (1), 188 (2025).","journal-title":"BMC Endocr. Disord."},{"issue":"2","key":"51951_CR43","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3126\/jmcjms.v9i2.43263","volume":"9","author":"SK Chaudhary","year":"2021","unstructured":"Chaudhary, S. K. Polypharmacy among geriatric people: Community pharmacy based study in Bhaktapur district. Nepal. Janaki Med. Coll. J. Med. Sci. 9 (2), 27\u201333 (2021).","journal-title":"Nepal. Janaki Med. Coll. J. Med. Sci."},{"issue":"2","key":"51951_CR44","doi-asserted-by":"publisher","first-page":"e041728","DOI":"10.1136\/bmjopen-2020-041728","volume":"11","author":"UN Yadav","year":"2021","unstructured":"Yadav, U. N. et al. Prevalence of non-communicable chronic conditions, multimorbidity and its correlates among older adults in rural Nepal: A cross-sectional study. BMJ Open. 11 (2), e041728 (2021).","journal-title":"BMJ Open."},{"issue":"4","key":"51951_CR45","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.amjopharm.2007.12.002","volume":"5","author":"ER Hajjar","year":"2007","unstructured":"Hajjar, E. R., Cafiero, A. C. & Hanlon, J. T. Polypharmacy in elderly patients. Am. J. Geriatr. Pharmacother. 5 (4), 345\u2013351 (2007).","journal-title":"Am. J. Geriatr. Pharmacother."},{"key":"51951_CR46","doi-asserted-by":"crossref","unstructured":"Elnaem, M. H. et al. Impact of medication regimen simplification on medication adherence and clinical outcomes in patients with long-term medical conditions. Patient Prefer. Adher. 2:2135\u20132145 (2020).","DOI":"10.2147\/PPA.S268499"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51951-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51951-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51951-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:58:26Z","timestamp":1783645106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51951-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["51951"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-51951-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"16 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received ethical approval from the Institutional Review Committee of Pokhara University (Ref. no.: 76\/2080\/2081). Permission for data collection was also obtained from the Health Service Office and Dailekh District Hospital (Ref. no.: 950\/2080\/81). All research was performed in accordance with relevant guidelines\/regulations and in accordance with the Declaration of Helsinki. Written informed consent was obtained from all participants before enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21598"}}